Clinical trial · Interventional
EMR Chemotoxicity Risk Calculator To Decrease Chemotherapy Toxicity
Effect of an EMR Chemotoxicity Risk Calculator Availability To Decrease Chemotherapy Toxicity in Adults With Cancer
NCT05809557CI-TRIAL-00074433completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
This study will formally test the quality improvement intervention of an EMR based tool that informs medical oncologists visiting a patient for the first time of potential risk of chemotherapy toxicity.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Chemotherapeutic Toxicity | — | UNRESOLVED | — |
| Metastatic Solid Tumor | Solid Neoplasm | CURATED_BROADER | 0.80 |
| Oncology | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Chemotherapy toxicity tool | Other | — | UNRESOLVED |
| Oncology Consultation | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- PLACEBO_COMPARATOR
- label
- Usual Care
- interventionNames
- Other: Oncology Consultation
- type
- EXPERIMENTAL
- label
- Chemotherapy Toxicity Tool
- interventionNames
- Other: Chemotherapy toxicity tool
- Other: Oncology Consultation
Primary outcomes (1)
- measure
- Unplanned hospitalization rate
- timeFrame
- Within 3 months of the Index Visit with the oncologist
- description
- Measured at the patient level as a binary outcome (yes/no) based on date of initial visit with the oncologist.
Secondary outcomes (5)
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 65 Years
Show eligibility criteria text
Inclusion Criteria: * New outpatient visits with a medical oncologist following a new diagnosis of cancer and no prior history of chemotherapy treatment. * aged \> 65 will be included. Exclusion Criteria: * Patients who opt out of clinical research will be excluded from analysis, but not the intervention (which will be applied to all patients). Specifically, as sometimes opt-in/opt out status is coded ambiguously in the data we will only analyze results of patients with clear opt in and no history of opt out. * Patients with no EHR data after initial oncologist appointment.
References
Publications (0)
Data not yet available
No reference posted for this study.